BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Harwood Feffer LLP Announces Investigation of ISTA Pharmaceuticals, Inc. (ISTA)


3/28/2012 9:56:20 AM

NEW YORK, March 27, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of ISTA Pharmaceuticals, Inc. ("ISTA" or the "Company") (NASDAQ: ISTA) concerning the proposed acquisition of the Company by Bausch & Lomb in a transaction valued at approximately $500 million.

(Logo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

On March 27, 2012, it was announced that ISTA and Bausch & Lomb have entered into a definitive agreement pursuant to which Bausch & Lomb will acquire ISTA. Under the agreement, ISTA shareholders will receive $9.10 in cash per share held. At least one analyst has set a target price for ISTA stock of $12.00 per share.

Our investigation concerns whether the board of directors is fulfilling its fiduciary duties, maximizing the value of ISTA, disclosing all material benefits and costs and obtaining full and fair consideration for ISTA shareholders.

If you own ISTA shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.

Benjamin Sachs-Michaels

Harwood Feffer LLP

488 Madison Avenue

New York, New York 10022

Phone Numbers:

(877) 935-7400

(212) 935-7400

Email: bsachsmichaels@hfesq.com

Website: http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Harwood Feffer LLP



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES